Palisade Bio
PALI
1 hedge funds and large institutions have $11.7M invested in Palisade Bio in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
8% more capital invested
Capital invested by funds: $10.8M → $11.7M (+$835K)
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$847K |
| 2 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$231K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29K |
| 4 |
D.E. Shaw & Co
New York
|
-$28K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GIA
26
GHP Investment Advisors
Denver,
Colorado
| $29K | – | – | – |
|
|
OC
27
Oppenheimer & Co
New York
| $29K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $29K | – | – | – |
|
|
WEC
29
Winslow Evans & Crocker
Boston,
Massachusetts
| $9K | – | – | – |
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $8K | – | – | – |
|
31
Citigroup
New York
| $6K | – | – | – |
|
|
OIA
32
Optimum Investment Advisors
Chicago,
Illinois
| $6K | – | – | – |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
34
AllianceBernstein
Nashville,
Tennessee
| $1K | – | – | – |
|
35
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
36
Creative Planning
Overland Park,
Kansas
| – | -$3K | – | – |
|
|
DCM
37
DAFNA Capital Management
Los Angeles,
California
| – | -$847K | – | – |
|
|
38
D.E. Shaw & Co
New York
| – | -$28K | – | – |
|
|
FAAS
39
First Allied Advisory Services
San Diego,
California
| – | -$231K | – | – |
|
40
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$9 | – | – |
|
|
41
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$29K | – | – |
|
PALI Hedge Fund Activity: Q4 2013 in Review
1 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2013, worth a combined $11.7M — up 7.7% from $10.8M a quarter earlier.
Fund positioning in PALI was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was DAFNA Capital Management, cutting an estimated $847K.
- 1 institutional investor held Palisade Bio (PALI) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $11.7M of Palisade Bio stock for Q4 2013, up 7.7% quarter-over-quarter.
- 0 funds opened new Palisade Bio positions in Q4 2013 and 0 closed out.
- The largest Palisade Bio seller in Q4 2013 was DAFNA Capital Management, an estimated $847K sold.
Based on aggregated 13F filings for Q4 2013.